Respiratory drug/device for the treatment of asthma & COPD
Rapid repair & recovery of acutely injured peripheral nerves
Oncology point-of-care diagnostics ($100M IPO in 2015)
Alzheimer’s therapeutics (sold to Allergan for $1B in 2016)
Ocular therapeutics (sold to Santen Pharma for $139M in 2011)
INTERESTED IN THE LATEST FROM NEW RHEIN? VIEW OUR COMPANY NEWS, PRESS RELEASES & INDUSTRY ARTICLES.